Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Clinical trial NCT06158100 · TERMINATED
Trial details
- NCT number
- NCT06158100
- Sponsor
- Antonio M Jimenez Jimenez
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-04
- Primary completion
- 2026-06-02
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.